InsideArbitrage Event Driven Monitor – February 24, 2025

Merger Arbitrage

1. BLUE: The acquisition of bluebird bio, Inc. (BLUE) by Carlyle (CG) and SK Capital Partners, for a closing value of $156.05 million. Under the terms of the agreement, bluebird stockholders will receive $3.00 per share in cash and a contingent value right per share, entitling the holder to a payment of $6.84 in cash per contingent value right if bluebird’s current product portfolio achieves $600 million in net sales in any trailing 12-month period prior to or ending on December 31, 2027. (Press Release)
2. DM: Desktop Metal (DM) announced that the Delaware Court of Chancery has set trial dates of March 11-12, 2025 in Desktop Metal’s pending litigation against Nano Dimension (NNDM) regarding the merger agreement between the parties. The Court granted Desktop Metal’s motion to expedite proceedings at a hearing in December 2024, finding that an expedition was warranted to address Desktop Metal’s claims under the Merger Agreement.
3. OMIC: The acquisition of Singular Genomics Systems (OMIC) by Deerfield Management Company was completed on February 21, 2025. It took 60 days for the deal to be completed.

You can check out new deals, all deal updates, and spreads on active deals in our Merger Arbitrage Tool for premium members here.

Only plus or premium subscribers can access this post. Subscribe today.